Overall, this retrospective case-control study reveals that decreased sensitivity of the CaSR to calcium due to inactivating polymorphisms at rs1801725 may predispose BC patients to high circulating calcium-driven larger or aggressive breast tumors. The gene discussed is CASR; the disease is breast neoplasm.